SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-20-032657
Filing Date
2020-03-13
Accepted
2020-03-12 19:21:02
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm201145d1_s3.htm S-3 350355
2 EXHIBIT 4.24 tm201145d1_ex4-24.htm EX-4.24 401377
3 EXHIBIT 5.1 tm201145d1_ex5-1.htm EX-5.1 34335
4 EXHIBIT 23.1 tm201145d1_ex23-1.htm EX-23.1 2867
5 GRAPHIC tm201145d1_s3img01.jpg GRAPHIC 3202
6 GRAPHIC tm201145d1_ex5-1img001.jpg GRAPHIC 3396
7 GRAPHIC tm201145d1_ex5-1img002.jpg GRAPHIC 3743
  Complete submission text file 0001104659-20-032657.txt   804728
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-237142 | Film No.: 20710286
SIC: 2836 Biological Products, (No Diagnostic Substances)